Daniel Wolf's practice focuses on mergers and acquisitions where he represents public and private companies, as well as private equity firms, in a variety of domestic and international transactions. His transactional experience spans the range of M&A activity including many significant cross-border and contested transactions. He also counsels public company clients on governance, finance, securities and other general corporate matters.
Daniel's transactional work has been recognized by numerous legal and financial publications. In 2012, he was named an "M&A MVP" in Law360's "MVPs of the Year" list for his work on some of the year's most high-profile and complex deals. In 2011 and 2012, Chambers and Partners listed Daniel as a top M&A attorney in Chambers USA: America's Leading Lawyers for Business, while Law360 named him one of its five "Rising Stars" in M&A under the age of 40. In 2008, Investment Dealers' Digest named Daniel to its '40 Under 40' list, and in 2007 The New York Times also named him as one of the "next generation of deal makers" under the age of 40. Daniel was also listed as a "Rising Star" by Super Lawyers magazine in 2011 and 2012 and endorsed by PLC's Mergers and Acquisitions multi-jurisdictional guide in 2012.
In addition, as a leading contributing author of the Kirkland M&A Update, Daniel's thought leadership has been recognized by various academic and business publications including The Wall Street Journal, The Harvard Law School Forum on Corporate Governance and Financial Regulation, The New York Times' Deal Professor, Investment Dealers' Digest, Deal Lawyers, Practical Law Company (PLC) and LAW360.
Daniel has advised clients on numerous significant negotiated and contested merger and acquisition transactions, including the representation of:
Vista Equity Partners in its pending $1.0 billion acquisition of Websense, Inc.
The Blackstone Group in its approximately $26 billion acquisition proposal for Dell Inc.
Bristol-Myers Squibb in its collaboration arrangement with Reckitt Benckiser for distribution and future acquisition of several of BMS' over-the-counter medicines sold primarily in Brazil and Mexico
Avis Budget Group, Inc. in its $500 million acquisition of Zipcar, Inc.
Duff & Phelps Corporation in its $665 million pending acquisition by a private equity consortium led by The Carlyle Group
Bristol-Myers Squibb in the $7 billion acquisition of Amylin Pharmaceuticals and related joint collaboration with AstraZeneca plc
ABB Ltd, the Swiss conglomerate, in its $3.9 billion acquisition of Thomas & Betts Corporation
Prestige Brands in connection with Genomma Lab's unsolicited $834 million acquisition proposal and potential proxy contest
Bristol-Myers Squibb Company in its $2.5 billion acquisition of Inhibitex, Inc.
Tronox Incorporated in its $3.4 billion acquisition of the South African and Australian mineral sands business of Exxaro Resources Ltd. of South Africa
Avis Budget Group, Inc. in its $1.0 billion acquisition of Avis Europe plc
Golden Gate Capital in its $470 million acquisition of California Pizza Kitchen
Danaher Corporation in its $685 million sale of its Pacific Scientific Aerospace business to Meggitt PLC
ABB Ltd, the Swiss conglomerate, in its $4.2 billion acquisition of Baldor Electric Company
Bristol-Myers Squibb Company in its $885 million acquisition of ZymoGenetics, Inc.
Avis Budget Group, Inc. in its unsolicited $1.5 billion offer to acquire Dollar Thrifty Automotive Group, Inc.
Danaher Corporation in the $650 million acquisition of MDS Analytical Technologies from MDS Inc. and in the related $450 million acquisition of a 50% stake in the Applied Biosystems/MDS SCIEX joint venture from Life Technologies Corporation
BHP Billiton in its approximately $150 billion withdrawn acquisition of Rio Tinto
American General Corporation in its $25 billion merger-of-equals transaction with Prudential plc and subsequent hostile takeover by American International Group (AIG)
Cendant Corporation (now Avis Budget Group, Inc.) in its separation into four companies through the spin-offs of its Realogy and Wyndham Worldwide divisions and the $4.3 billion sale of its Travelport division to the Blackstone Group
ECI Telecom Ltd. in its $1.2 billion buyout by a private equity consortium in the first significant private equity buyout of an Israeli public company
consortium of buyers in the approximately $800 million announced leveraged buyout of Winston Hotels, Inc., a public hotel REIT
Gerson Lehrman Group, Inc. in the investment by Silver Lake of approximately $200 million
Fox Paine & Company, LLC, a leading private equity firm, and many of its portfolio companies in numerous M&A and finance transactions
Dresdner Bank AG in its acquisition of the investment banking business of Wasserstein Perella Group, Inc.
Knight Capital Group, Inc. in numerous acquisitions and dispositions in its global markets and asset management divisions
Leonard Green & Partners in its leveraged buyout of Twinlab Corporation and subsequent high-yield debt, and initial and secondary equity public offerings
AboveNet Communications Inc. in its $1.6 billion merger with Metromedia Fiber Network, Inc.
Syncor International Corporation in its $1 billion acquisition by Cardinal Health
Daniel also has an active practice representing both issuers and underwriters in equity and high-yield debt financings. His work in this area includes the representation of investment banks in the financing of recapitalizations and other buyout or going-private transactions. Recent transactions include the representation of Janus Capital Group in its approximately $400 million offering of common stock and convertible notes, and related tender offer for outstanding senior notes.